Daiichi Sankyo (OTCPK:DSKYF) stock slid 10% Friday after the Japanese drugmaker announced it had received approval in Japan for its DXd antibody-drug conjugate Datroway for the treatment of HR+ ...

AstraZeneca and Daiichi Sankyo have moved swiftly to file for FDA approval of a second indication for their TROP2-directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd), this time for ...

In tandem with Enhertu’s inclusion in China’s national insurance program, Daiichi Sankyo is planting a foothold in local production. Daiichi will invest 1.1 billion Chinese yuan ($152 million ...

8316.T Sumitomo Mitsui Financial Group, Inc.

Daiichi Sankyo has made a little bit of pharma industry history, becoming the first drugmaker to win approval in Japan for a therapy for cancer based on a virus that selectively kills malignant cells.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The Bluevine Business Checking account has no monthly fees, overdraft fees or transaction fees and does not require a minimum opening deposit. This high-yield account also boasts a great interest ...

Commissions do not affect our editors' opinions or evaluations. Choosing a bank can be daunting, given that there are more than 4,500 federally insured banks in the U.S. to choose from.

The humpback that washed up dead in Long Beach this week has been identified as NYC0393, a playful and spirited cetacean who had become familiar to whale watchers last summer for her acrobatic ...

If you click on links we provide, we may receive compensation. Inexpensive accounts, but lacking competitive savings rates TD Bank Our Take TD Bank has roots dating back to 1855. A subsidiary of ...

Daiichi Sankyo has announced the dosage of the first subject in the randomised Phase III QuANTUM-Wild trial of oral Vanflyta (quizartinib) in adults with newly diagnosed, FLT3-ITD negative acute ...